COVID-19疫苗犹豫量表:孕妇和哺乳者及父母的心理测量特性和验证

IF 2.2 Q3 IMMUNOLOGY
Heidi Sze Lok Fan , Edmond Pui Hang Choi , Elizabeth Keys , Rishma Chooniedass , Stephanie Masina , Alex Halonen , Kalysse Mantai , Marie Tarrant
{"title":"COVID-19疫苗犹豫量表:孕妇和哺乳者及父母的心理测量特性和验证","authors":"Heidi Sze Lok Fan ,&nbsp;Edmond Pui Hang Choi ,&nbsp;Elizabeth Keys ,&nbsp;Rishma Chooniedass ,&nbsp;Stephanie Masina ,&nbsp;Alex Halonen ,&nbsp;Kalysse Mantai ,&nbsp;Marie Tarrant","doi":"10.1016/j.jvacx.2025.100720","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The Vaccine Hesitancy Scale (VHS) was developed by the World Health Organization's Strategic Advisory Group of Experts on Immunization (SAGE) to examine parents' vaccine hesitancy toward childhood vaccines. The VHS has been validated and modified to assess vaccine hesitancy toward specific vaccines, including influenza and human papillomavirus vaccines, but not the COVID-19 vaccine. The objective of this study is to validate a modified VHS for the COVID-19 vaccine among pregnant and breastfeeding persons, and parents of children under 12 years of age.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted in British Columbia, Canada from October to December 2021. A total of 1510 participants including pregnant and breastfeeding persons, and parents of children &lt;12 years of age were included in the analysis. Participants completed questionnaires tailored to their respective groups based on self-identification. Confirmatory factor analysis was conducted to assess the original VHS structure. The data were then randomly split into training and validation sets for exploratory and confirmatory factor analyses. Factor structure, internal construct validity, internal consistency, and known-group validity were evaluated.</div></div><div><h3>Results</h3><div>The original VHS model showed a poor fit. Exploratory factor analysis identified a revised one-factor model (VHS-COVID19), which showed satisfactory fit in the validation sample for pregnant participants (comparative fit index [CFI] = 0.999; root mean square error of approximation [RMSEA] = 0.041; standardized root mean squared residual [SRMR] = 0.008; Tucker-Lewis Index [TLI] = 0.997), breastfeeding participants (CFI = 0.995; RMAEA = 0.089; SRMR = 0.006; TLI = 0.990) and parent participants (CFI = 0.995; RMAEA = 0.080; SRMR = 0.004; TLI = 0.992). The revised scale comprised five items for pregnant and breastfeeding participants and six for parent participants<em>.</em> VHS-COVID19 showed high internal construct validity and reliability.</div></div><div><h3>Conclusions</h3><div>The VHS-COVID19 shows adequate psychometric performance for assessing COVID-19 vaccine hesitancy among pregnant, breastfeeding persons, and parents. It is easy to administer and can be used by healthcare providers to rapidly assess vaccine hesitancy of the targeted population in clinical settings.</div></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"27 ","pages":"Article 100720"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 Vaccine Hesitancy Scale: Psychometric properties and validation among pregnant and breastfeeding persons and parents\",\"authors\":\"Heidi Sze Lok Fan ,&nbsp;Edmond Pui Hang Choi ,&nbsp;Elizabeth Keys ,&nbsp;Rishma Chooniedass ,&nbsp;Stephanie Masina ,&nbsp;Alex Halonen ,&nbsp;Kalysse Mantai ,&nbsp;Marie Tarrant\",\"doi\":\"10.1016/j.jvacx.2025.100720\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The Vaccine Hesitancy Scale (VHS) was developed by the World Health Organization's Strategic Advisory Group of Experts on Immunization (SAGE) to examine parents' vaccine hesitancy toward childhood vaccines. The VHS has been validated and modified to assess vaccine hesitancy toward specific vaccines, including influenza and human papillomavirus vaccines, but not the COVID-19 vaccine. The objective of this study is to validate a modified VHS for the COVID-19 vaccine among pregnant and breastfeeding persons, and parents of children under 12 years of age.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted in British Columbia, Canada from October to December 2021. A total of 1510 participants including pregnant and breastfeeding persons, and parents of children &lt;12 years of age were included in the analysis. Participants completed questionnaires tailored to their respective groups based on self-identification. Confirmatory factor analysis was conducted to assess the original VHS structure. The data were then randomly split into training and validation sets for exploratory and confirmatory factor analyses. Factor structure, internal construct validity, internal consistency, and known-group validity were evaluated.</div></div><div><h3>Results</h3><div>The original VHS model showed a poor fit. Exploratory factor analysis identified a revised one-factor model (VHS-COVID19), which showed satisfactory fit in the validation sample for pregnant participants (comparative fit index [CFI] = 0.999; root mean square error of approximation [RMSEA] = 0.041; standardized root mean squared residual [SRMR] = 0.008; Tucker-Lewis Index [TLI] = 0.997), breastfeeding participants (CFI = 0.995; RMAEA = 0.089; SRMR = 0.006; TLI = 0.990) and parent participants (CFI = 0.995; RMAEA = 0.080; SRMR = 0.004; TLI = 0.992). The revised scale comprised five items for pregnant and breastfeeding participants and six for parent participants<em>.</em> VHS-COVID19 showed high internal construct validity and reliability.</div></div><div><h3>Conclusions</h3><div>The VHS-COVID19 shows adequate psychometric performance for assessing COVID-19 vaccine hesitancy among pregnant, breastfeeding persons, and parents. It is easy to administer and can be used by healthcare providers to rapidly assess vaccine hesitancy of the targeted population in clinical settings.</div></div>\",\"PeriodicalId\":43021,\"journal\":{\"name\":\"Vaccine: X\",\"volume\":\"27 \",\"pages\":\"Article 100720\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590136225001147\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136225001147","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

疫苗犹豫量表(VHS)是由世界卫生组织免疫战略咨询专家组(SAGE)制定的,用于检查父母对儿童疫苗的犹豫。VHS已经过验证和修改,以评估疫苗对特定疫苗的犹豫性,包括流感和人乳头瘤病毒疫苗,但不包括COVID-19疫苗。本研究的目的是在孕妇和哺乳者以及12岁以下儿童的父母中验证改进的COVID-19疫苗VHS。方法于2021年10 - 12月在加拿大不列颠哥伦比亚省进行横断面调查。共有1510名参与者,包括孕妇和母乳喂养者,以及12岁儿童的父母被纳入分析。参与者根据自我认同完成了针对各自群体的调查问卷。采用验证性因子分析对原始VHS结构进行评估。然后将数据随机分为探索性和验证性因素分析的训练集和验证集。评估因子结构、内部构念效度、内部一致性及已知组效度。结果原VHS模型拟合较差。探索性因子分析建立了改进的单因素模型(vhs - covid),孕妇(比较拟合指数[CFI] = 0.999,近似均方根误差[RMSEA] = 0.041,标准化均方根残差[SRMR] = 0.008,塔克- lewis指数[TLI] = 0.997)、母乳喂养参与者(CFI = 0.995, RMAEA = 0.089, SRMR = 0.006, TLI = 0.990)和父母参与者(CFI = 0.995, RMAEA = 0.080, SRMR = 0.004, RMAEA = 0.09)与验证样本拟合良好。tli = 0.992)。修订后的量表包括孕妇和哺乳期参与者的5个项目和父母参与者的6个项目。VHS-COVID19具有较高的内部结构效度和信度。结论VHS-COVID19在评估孕妇、哺乳期人员和父母的COVID-19疫苗犹豫方面表现良好。它易于管理,可由卫生保健提供者在临床环境中用于快速评估目标人群的疫苗犹豫。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
COVID-19 Vaccine Hesitancy Scale: Psychometric properties and validation among pregnant and breastfeeding persons and parents

Introduction

The Vaccine Hesitancy Scale (VHS) was developed by the World Health Organization's Strategic Advisory Group of Experts on Immunization (SAGE) to examine parents' vaccine hesitancy toward childhood vaccines. The VHS has been validated and modified to assess vaccine hesitancy toward specific vaccines, including influenza and human papillomavirus vaccines, but not the COVID-19 vaccine. The objective of this study is to validate a modified VHS for the COVID-19 vaccine among pregnant and breastfeeding persons, and parents of children under 12 years of age.

Methods

A cross-sectional survey was conducted in British Columbia, Canada from October to December 2021. A total of 1510 participants including pregnant and breastfeeding persons, and parents of children <12 years of age were included in the analysis. Participants completed questionnaires tailored to their respective groups based on self-identification. Confirmatory factor analysis was conducted to assess the original VHS structure. The data were then randomly split into training and validation sets for exploratory and confirmatory factor analyses. Factor structure, internal construct validity, internal consistency, and known-group validity were evaluated.

Results

The original VHS model showed a poor fit. Exploratory factor analysis identified a revised one-factor model (VHS-COVID19), which showed satisfactory fit in the validation sample for pregnant participants (comparative fit index [CFI] = 0.999; root mean square error of approximation [RMSEA] = 0.041; standardized root mean squared residual [SRMR] = 0.008; Tucker-Lewis Index [TLI] = 0.997), breastfeeding participants (CFI = 0.995; RMAEA = 0.089; SRMR = 0.006; TLI = 0.990) and parent participants (CFI = 0.995; RMAEA = 0.080; SRMR = 0.004; TLI = 0.992). The revised scale comprised five items for pregnant and breastfeeding participants and six for parent participants. VHS-COVID19 showed high internal construct validity and reliability.

Conclusions

The VHS-COVID19 shows adequate psychometric performance for assessing COVID-19 vaccine hesitancy among pregnant, breastfeeding persons, and parents. It is easy to administer and can be used by healthcare providers to rapidly assess vaccine hesitancy of the targeted population in clinical settings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信